Jakub Gołąb

Last Monday, June 15th the Department of Immunology at the Medical University of Warsaw held a meeting with a BATION guest: Theresa L. Whiteside, PhD, MDHC Professor of Pathology, Immunology and Otolaryngology University of Pittsburgh Cancer Institute. The title of her lecture was “Regulators T-cell networks in human cancers and immune therapy”. Professor Theresa L. […] ›

Sorry, this entry is only available in Polski. ›

Sorry, this entry is only available in Polski. ›

On February 18th in European Journal of Cancer (EJC) an articleentitled 5-Aza-2’-deoxycytidine potentiates antitumor immune response induced by photodynamic therapy has been published. The study was focused on  antitumor effect of photodynamic therapy combined with 5-aza-2’-deoxycytidine, a methyltransferase inhibitor. Our observation suggest that clinically approved epigenetic agent 5-aza-2’-deoxycytidine can improve PDT induced antitumor immune response leading to […] ›

On January 10th the latest study have been published in the Leukemia magazine. The study was focused on the effect of B-cell receptor signaling pathway inhibitors on surface CD20 levels and antitumor efficacy of anti-CD20 monoclonal antibodies. For the first time researchers have reported that blocking the activity of BCR signaling pathway using small molecule […] ›

In the latest issue of Angiogenesis (in print) an article of prof. Golab’s team has been published: Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis.  ›